|| SHANIWAR SAMWAD || 11-03-2023

 Recently, a report came from a US agency for the deaths of children in Gambia, that it was due to defective syrup supplied from India.

It is after one such report came from the western world for the death of some children from a central Asian country.

When the first incident occurred, the WHO gave the name of the supplier and preliminary report, not the final report. At that time government not only closed that plant but also ordered inquiries on its process and production.

The report for contamination charges proved false and also final report from WHO also did not give any evidence for its charges.

At the Davos Meet which was held sometime this year back, a piece of sensational news came from Pfizer, which is one of the renowned drug suppliers and major pharma corporate based in the US that tried hard to influence the government of India for its vaccine on covid19.

The actual cost of the lobby was not revealed but it is something in Billions of Dollars to media and other influential people. Which was miserably failed to get orders.

The recent report came after, the German government accepted for symptoms of HIV in the people who took the Pfizer vaccine, both Pfizer and Moderna tried every possible way to get its vaccine accepted by countries with high and exorbitant rates.

We actually vaccinated our citizens in both doses at a fraction of the cost in comparison to their single dose.

The cost and requirement of the cooling plant made it unviable to most countries with their condition to get it.

On the contrary, we gave vaccines free of cost to most countries, especially to poor ones, and as per their demand to reduce mortality, at that time Pfizer used all means to defame our one producer who was supplying vaccines to Brazil. This also proved false propaganda and our supply resumed after all things settled in our favor.

The total generic supply from the country is around 25%  to the US and the same quantity is in Western Europe with this we are not only supplying by contract manufacturing or own labels with approval from US FDA with superior  R & D capability is giving the big corporates a headache which is going to increase with time.

The recent report is not going to stand with importing countries as they are getting cheap and quality drugs with assurance from our Government.

But, this is also a warning bell to be alert, so as not to lose sight and market, with enhancing the quality of our product and services.






Comments

Popular posts from this blog

FINANCIAL PLANNING REVISITED

|| SHANIWAR SAMWAD || 22-10-2022

|| SHANIWAR SAMWAD || 11-12-2021